Perrigo (NYSE:PRGO) had its price target upped by Barclays to $93.00 in a research note issued to investors on Monday. The firm presently has an “overweight” rating on the stock. Barclays’ price target points to a potential upside of 6.90% from the company’s current price.

Several other analysts have also recently weighed in on PRGO. BidaskClub cut Perrigo from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 9th. Canaccord Genuity reissued a “buy” rating and set a $88.00 price objective (up from $80.00) on shares of Perrigo in a report on Thursday, August 10th. Cantor Fitzgerald set a $93.00 price objective on Perrigo and gave the stock a “buy” rating in a report on Thursday, August 10th. Goldman Sachs Group raised Perrigo from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $66.00 to $79.00 in a report on Friday, August 11th. Finally, Royal Bank Of Canada boosted their target price on Perrigo from $60.00 to $64.00 and gave the stock an “underperform” rating in a research report on Friday, August 11th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $92.07.

Perrigo (NYSE PRGO) traded down $0.21 during trading on Monday, hitting $87.00. The company had a trading volume of 834,500 shares, compared to its average volume of 1,701,456. The company has a market capitalization of $12,253.14, a PE ratio of 17.75, a price-to-earnings-growth ratio of 1.85 and a beta of 0.70. Perrigo has a fifty-two week low of $63.68 and a fifty-two week high of $91.73. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Thursday, November 9th. The company reported $1.39 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.28. The firm had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The company’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.65 EPS. equities analysts predict that Perrigo will post 4.88 EPS for the current fiscal year.

In related news, EVP John Wesolowski sold 388 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $87.20, for a total value of $33,833.60. Following the completion of the transaction, the executive vice president now directly owns 248 shares in the company, valued at approximately $21,625.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Jeffrey Needham sold 3,595 shares of the business’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $89.49, for a total value of $321,716.55. Following the completion of the transaction, the executive vice president now owns 10,118 shares of the company’s stock, valued at $905,459.82. The disclosure for this sale can be found here. Insiders have sold a total of 4,514 shares of company stock valued at $400,009 over the last 90 days. Corporate insiders own 6.90% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of PRGO. Allen Investment Management LLC boosted its position in Perrigo by 7.1% during the 2nd quarter. Allen Investment Management LLC now owns 7,143 shares of the company’s stock worth $539,000 after acquiring an additional 473 shares during the last quarter. State Street Corp boosted its position in Perrigo by 1.7% during the 2nd quarter. State Street Corp now owns 6,757,086 shares of the company’s stock worth $510,294,000 after acquiring an additional 112,287 shares during the last quarter. Sei Investments Co. boosted its position in Perrigo by 7.5% during the 3rd quarter. Sei Investments Co. now owns 131,284 shares of the company’s stock worth $11,114,000 after acquiring an additional 9,192 shares during the last quarter. Andra AP fonden boosted its position in Perrigo by 9.9% during the 3rd quarter. Andra AP fonden now owns 16,700 shares of the company’s stock worth $1,414,000 after acquiring an additional 1,500 shares during the last quarter. Finally, Monetta Financial Services Inc. acquired a new position in Perrigo during the 2nd quarter worth approximately $755,000. Institutional investors and hedge funds own 85.53% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Barclays Raises Perrigo (PRGO) Price Target to $93.00” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/04/barclays-raises-perrigo-prgo-price-target-to-93-00.html.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Stock Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related stocks with our FREE daily email newsletter.